PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE
Post-LOEphentermine and topiramate extended-release
ANDAORALCAPSULE, EXTENDED RELEASE
Approved
Jun 2025
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
2/8 — Basic
PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE (phentermine and topiramate extended-release) by Dr. Reddy's Laboratories is cytochrome p450 3a4 inducers [moa]. First approved in 2025.
Drug data last refreshed 18h ago
Mechanism of Action
Cytochrome P450 3A4 Inducers
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Worked on PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE at Dr. Reddy's Laboratories? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.